You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PO006LBA/#1520  Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

Citation Tools

Article menu

Download PDFPDF

Plenary 02: Changing the Landscape of Endometrial Cancer
AS04. Endometrial/Uterine corpus cancers
PO006LBA/#1520  Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Scambia G, Vergote I, Hamilton E, et al
PO006LBA/#1520  Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
International Journal of Gynecologic Cancer 2023;33:A5.